Mat Su Health Services, Inc Wasilla, Alaska, United States
Learn how medication-assisted treatment (MAT) is used to treat substance use disorders for relapse prevention, harm reduction, and overdose prevention. Medication-assisted treatment (MAT) is part of the “whole-person centered care” approach in the treatment of substance use disorders. Research supports that medication and psychosocial support therapy can provide better patient outcomes for people with a history of chemical dependency and addiction. MAT can help sustain those recovery efforts.
As part of the session, we will help identify patients who are appropriate for MAT therapy for the treatment of alcohol and opioid use disorder and also review and compare additional treatment options for other substances, including cannabis, methamphetamine, and cocaine. We will recognize the process of stabilizing, maintaining, monitoring, and modifying the treatment of patients on buprenorphine and other MAT options. We will review the benefits of incorporating the NSS-2 Bridge device to manage opioid withdrawal symptoms while transitioning from the use of opioids.
This session has been approved by NBCC for NBCC credit.
Learning Objectives:
After this activity participants should be able to
Identify and assess patients who are appropriate for treatment with buprenorphine/naloxone for opioid use disorder
Compare buprenorphine induction protocols for home versus clinic induction, stabilizing, monitoring and modifying treatment of patients on buprenorphine
Describe NSS-2 Bridge Device and its impact on transitions of care for the treatment of opioid use disorder